We believe that the improved affinity of the HER3-binders as well as the demonstrated receptor-specific uptake of the Affibody molecules in HER3-expressing organs in mice are valuable attributes for successful tumor uptake and retention, enabling potential treatment of human cancers dependent on functional HER3-signaling using Z08698 and Z08699. Here, ERBB3 is linked to cancer.